v3.26.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Net sales $ 472,800 $ 450,900 $ 1,433,200 $ 1,395,000
Cost of sales 382,000 365,300 1,170,200 1,112,900
Gross profit 90,800 85,600 263,000 282,100
Selling, general and administrative expenses 59,900 57,500 181,700 173,600
Research and development costs 4,900 6,900 19,400 20,000
Recovery due to misappropriation of assets, net 0 (7,300) 0 (6,500)
Goodwill impairment 0 80,800 0 80,800
Other expenses, net 3,200 1,400 6,400 4,600
Income (loss) from operations 22,800 (53,700) 55,500 9,600
Interest and other financial expense, net 17,800 14,400 48,800 47,200
Income (loss) before earnings in affiliated companies and income taxes 5,000 (68,100) 6,700 (37,600)
Income tax expense (benefit) 8,200 (500) 18,300 13,000
Earnings in affiliated companies, net of tax 100 500 400 1,600
Net loss $ (3,100) $ (67,100) $ (11,200) $ (49,000)
Weighted-average shares outstanding (in thousands):        
Basic (in shares) 56,389 56,046 56,352 56,415
Diluted (in shares) 56,389 56,249 56,352 56,663
Loss per share:        
Basic (in USD per share) $ (0.05) $ (1.20) $ (0.20) $ (0.87)
Diluted (in USD per share) $ (0.05) $ (1.20) $ (0.20) $ (0.87)